This is a regulatory disclosure submitted to the Bombay Stock Exchange pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The Board of Directors meeting is scheduled to be held on Friday, 30th October, 2026 at 4:00 p.m. at the Corporate Office (95-96 C Mittal Court, Nariman Point, Mumbai 400 021). The primary agenda is to approve the Unaudited Financial Results for the Second quarter and Half Year ended September 30, 2026.
The trading window for dealing in the company's securities remains closed for all Designated Persons as defined in the Code of Conduct for prevention of Insider Trading, read with SEBI (Prohibition of Insider Trading) Regulations, 2015. The window will reopen 48 hours after the declaration of the Unaudited Financial Results for the Second quarter and Half Year ended September 30, 2026.
During the window closure period, dealings involving the purchase or sale of the company's shares by designated/connected persons, including their relatives, is strictly prohibited.